Skip to main content
. 2021 Jul 21:1–18. doi: 10.1017/cjn.2021.180

Figure 7.

Figure 7.

Forest plots from random-effects meta-analyses for two retrospective cohort studies examining (A) the proportion of patients with COVID-19 who develop Guillain–Barre Syndrome (GBS) and (B) comparing the occurrence of GBS in COVID-19 with control groups without COVID-19. In Figure 7B, the “Yes” columns indicate the number of patients in a given group (COVID-19 patients or control) who had GBS, while “No” indicates the number of patients who did not have this symptom.